The estimated Net Worth of Jasmine Kway is at least $7.27 millier dollars as of 24 August 2023. Jasmine Kway owns over 5,000 units of VolitionRX Ltd stock worth over $7,270 and over the last 5 years he sold VNRX stock worth over $0. In addition, he makes $0 as Chief Executive Officer of Singapore Volition at VolitionRX Ltd.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jasmine Kway VNRX stock SEC Form 4 insiders trading
Jasmine has made over 1 trades of the VolitionRX Ltd stock since 2023, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VNRX stock worth $6,000 on 24 August 2023.
The largest trade he's ever made was buying 5,000 units of VolitionRX Ltd stock on 24 August 2023 worth over $6,000. On average, Jasmine trades about 385 units every 0 days since 2020. As of 24 August 2023 he still owns at least 10,400 units of VolitionRX Ltd stock.
You can see the complete history of Jasmine Kway stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jasmine Kway biography
Dr. Jasmine Kway serves as Chief Executive Officer of Singapore Volition of the Company. Dr. Kway previously served as Singapore Volition’s Vice President of Asia from January 2017 until June 2018. Prior to joining Singapore Volition, during 2016 Dr. Kway served as Chief Executive Officer of intellectual property practice at RHT i-Assets Advisory, one of the leading companies of the RHT Group of Companies and RHT Holdings (RHT), a Singapore headquartered integrated leading professional services company providing professional services in Asia. While at RHT i-Assets Advisory, Dr. Kway was focused on managing buy-side and sell-side clients globally in technology/intellectual property transactions, business development, and fund raising. Prior to RHT i-Assets Advisory, Dr. Kway worked in both the private and public sectors, including as Executive Vice President, Business Development at Transpacific IP Group Limited from 2010 to 2015, and as Director of Industry Liaison of the National University of Singapore from 2005 to 2010. In these positions, Dr. Kway formulated and implemented national intellectual property policies, corporate intellectual property strategies and management, intellectual property and technology development, commercialization, fundraising, and investment. Our board of directors believes that Dr. Kway’s extensive prior management experience, including with respect to intellectual property matters, is an asset to us in her role as Chief Executive Officer of Singapore Volition.
How old is Jasmine Kway?
Jasmine Kway is 48, he's been the Chief Executive Officer of Singapore Volition of VolitionRX Ltd since 2018. There are 14 older and 4 younger executives at VolitionRX Ltd. The oldest executive at VolitionRX Ltd is Dr. Martin Charles Faulkes Ph.D., 77, who is the Exec. Chairman.
What's Jasmine Kway's mailing address?
Jasmine's mailing address filed with the SEC is 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014.
Insiders trading at VolitionRX Ltd
Over the last 12 years, insiders at VolitionRX Ltd have traded over $775,239 worth of VolitionRX Ltd stock and bought 1,908,474 units worth $44,487,770,972 . The most active insiders traders include Guy Archibald Innes, Cameron John Reynolds et Martin Charles Faulkes. On average, VolitionRX Ltd executives and independent directors trade stock every 43 days with the average trade being worth of $27,899. The most recent stock trade was executed by Guy Archibald Innes on 20 August 2024, trading 150,000 units of VNRX stock currently worth $100,500.
What does VolitionRX Ltd do?
volitionrx is a life sciences company whose goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats. volitionrx’s development activities are currently centered in belgium with a focus on bringing its revolutionary diagnostic products to market first in europe, then the u.s. and worldwide. you can find more information about volitionrx at our website at www.volitionrx.com, on twitter at www.twitter.com/volitionrx, linkedin at http://www.linkedin.com/company/volitionrx or facebook at www.facebook.com/volitionrx.
What does VolitionRX Ltd's logo look like?
Complete history of Jasmine Kway stock trades at VolitionRX Ltd
VolitionRX Ltd executives and stock owners
VolitionRX Ltd executives and other stock owners filed with the SEC include:
-
Cameron Reynolds,
President, Chief Executive Officer, Director -
Cameron Reynolds MBA,
Founder, Group CEO, Pres & Director -
Jason Terrell,
Chief Medical Officer and Head of US Operations -
Dr. Jason Bradley Terrell,
Chief Medical Officer & Head of U.S. Operations -
David Vanston,
Chief Financial Officer, Treasurer -
Jacob Micallef,
Chief Scientific Officer -
Martin Faulkes,
Executive Chairman of the Board -
Rodney Rootsaert,
Corporate Secretary -
Dr. Martin Charles Faulkes Ph.D.,
Exec. Chairman -
Dr. Jacob Vincent Micallef,
Chief Scientific Officer -
Dr. Salvatore Thomas Butera,
Chief Exec. Officer of Volition Veterinary Diagnostics Devel. LLC -
Scott Powell,
IR Contact Officer -
Guy Innes,
Independent Director -
Edward Futcher,
Independent Director -
Alan Colman,
Independent Director -
Phillip Barnes,
Independent Director -
Gaetan Michel,
Chief Executive Officer of Belgian Volition -
Jasmine Kway,
Chief Executive Officer of Singapore Volition -
Nick Plummer,
Group Gen. Counsel -
Scott Powell Ph.D.,
Exec. VP of Investor Relations & CFO of Volition America Inc -
Dr. Mark Eccleston M.B.A., Ph.D.,
Chief Technology Officer -
Dr. Gaetan Michel Ph.D.,
Chief Operating Officer -
Terig Hughes,
Group CFO & Treasurer -
Corp Ltd Cotterford Co Ltd ...,
-
Richard Brudnick,
-
Habib Skaff,
Director -
David Matthew Kratochvil,
Chief Financial Officer -
Rodney Gerard Concord Inter...,
Secretary -
Nicholas Plummer,
GC - Volition Diagnostics -
Ann Louise Batchelor,
Group Chief Marketing Officer -
Kim Nguyen,
-
Terig Hughes,
Chief Financial Officer -
Mickie Henshall,
-
Gael Forterre,
Chief Commercial Officer -
Corp Ltd Hever Investments ...,
-
Salvatore Thomas Butera,
CEO - Volition Veterinary